加味痛泻要方治疗肠易激综合征疗效观察

Clinical Effect of Jiaweitongxie Prescription in Treating Irritable Bowel Syndrome

目的:观察加味痛泻要方治疗腹泻型肠易激综合征(IBS)的临床疗效。方法:对80例符合罗马Ⅲ诊断标准的IBS患者随机分为治疗组和对照组。治疗组采用加味痛泻要方治疗,对照组用得舒特治疗,同时口服培菲康调节肠道菌群。结果:总有效率治疗组90%,对照组70%,两组比较,P<0.05;治疗组患者腹痛、泄泻改善明显优于对照组,且不良反应的发生率低于对照组。结论:加味痛泻要方治疗IBS疗效优于单纯西医治疗。

Objective ：To observe the clinical effect of Jiaweitongxie prescription in the treatment of diarrhea-predominant irritable bowel syndrome （IBS）. Methods：80 cases of IBS according to the Rome Ⅱ criteria were randomly divided into the treatment group and the contrast group. The treatment group was treated by Jiaweitongxie prescription. The contrast group was treated by Shutc, with peifeikang to adjust the germ in bowel. Results：The total effective ratio of the treatment group and the contrast group was 90% and 70% respectively. The treatment group was better than the contrast group in improvement of abdominal pain and stool. The ratio of side-effect of the treatment group was also lower than that of the contrast group. Conclusion ：Jiaweitongxie prescription has a better effect in treating IBS than western medicine only.